New technology advances biopharma chromatography productivity

February 16, 2023

Monoclonal antibody drugs (mAbs) make up more than 50
percent of the biologics on the market today, as well as a
significant number of new drugs in the development pipeline. The value and impact of these therapies has been dramatic.

Spotlight

Doha Drug Store

Doha Drug Store, one of Qatar’s premier Trading Companies, represents a list of 46 exclusive agencies in the Consumer goods and Pharmaceutical (Generic & Research) Industries. Founded in 1960 by Nasser Bin Khalid & Ali Bin Ali, as a Pharmaceutical Trading Company, the firm has since grown into one of Qatar’s major fast moving consumer goods (FMCG) suppliers, which fully operates its own warehousing, distribution and retail outlets, bringing timely products and services to the customer. Doha Drug Store has a proud heritage of servicing Qatar’s consumer market. Its products are sourced from worldwide locations, which stretch across four continents. Having formed partnering relationships with well-established firms in their respective fields of manufacturing and supply, Doha Drug Store is committed to delivering quality to its valued customers.

OTHER WHITEPAPERS

Access to medicinal products

whitePaper | January 3, 2022

There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Association for Accessible Medicines Drug Shortages

whitePaper | June 22, 2023

Generic medicines are the backbone of the U.S. prescription drug market, supplying more than 9 out of every 10 prescriptions. And the availability of generic medicines overall is remarkably stable even during challenges such as the COVID-19 pandemic.

Combatting Future Viral Threats with Vaccine Advances

whitePaper | February 3, 2023

Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry.

Pharma R And D Review

whitePaper | February 11, 2021

Welcome to Pharmaprojects’ 2021 review of trends in pharmaceutical R&D. For almost 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article I’ll examine the state of play at the start of 2021.

Infosys and Top Pharma Bring Digital Transformation to DrugManufacturing Data

whitePaper | April 1, 2022

In 2017, a top 20 global pharmaceutical company began a journey to digitally transform its pharmaceutical engineering and manufacturing capabilities by constructing a data integration and visualization platform, with strategic assistance and technical implementation provided by its partner Infosys.